LANREOTIDE ACETATE Recalls

3 recalls found for LANREOTIDE ACETATE. Check if any of your products are affected.

Health & Personal Care

HIGH

FDA DRUG

Cipla USA Lanreotide Injection Recall for Sterility Assurance Issue (2026)

Cipla USA Inc. recalls 54,583 Lanreotide acetate injections nationwide after FDA flagged sterility assurance concerns at a contract manufacturer. The recall covers a box containing one pre-filled syringe and one safety needle. Healthcare providers and patients should stop using the product immediately and follow the company’s guidance for disposal and refunds.

Mar 13, 2026

LANREOTIDE ACETATE

Lack of

Health & Personal Care

HIGH

FDA DRUG

Lanreotide Injection recall: Cipla USA lanreotide acetate pre-filled syringes recalled for sterility

Cipla USA, Inc. recalls lanreotide acetate 120 mg/0.5 mL pre-filled syringes distributed nationwide due to lack of assurance of sterility after FDA observations at the contract manufacturer. Health care providers and patients should stop use immediately and contact Cipla or their clinician for guidance.

Mar 13, 2026

LANREOTIDE ACETATE

Lack of

Health & Personal Care

HIGH

FDA DRUG

Cipla Lanreotide Acetate Injection Recall: 15,221 Syringes Over Particulate Matter (2026)

Cipla USA, Inc. is recalling 15,221 Lanreotide Acetate Injection syringes nationwide in the United States after detecting particulate matter. The defect is the presence of particulate matter in the injectable solution. Healthcare providers and patients should stop using the product immediately and contact Cipla USA for guidance.

Jan 2, 2026

LANREOTIDE ACETATE

Presence of

Brand Statistics

Total Recalls

Pages

Related Brands

Cipla USA Inc.